ENG 
ESP 
Biophotomodulation
Amaurosis Fugax: Understanding Temporary Vision Loss and Stroke Risk
Have you experienced a sudden loss of vision in one eye? It could be amaurosis fugax (AFx) or a retinal transient ischemic attack (rTIA), an important warning sign for your vascular health. Learn what they are, why they happen, and why urgent diagnosis and treatment are needed to prevent a stroke.
What Are Amaurosis Fugax and rTIA?
Amaurosis fugax (AFx) is a transient monocular vision loss caused by temporary retinal ischemia. This means that blood flow to the retina drops suddenly and reversibly, often because of embolic events or hemodynamic changes.
rTIA is a more specific term for this momentary vision loss resulting from transient retinal ischemia. It is considered a type of transient ischemic attack (TIA) that affects the ocular circulation. The retina is highly sensitive to oxygen deprivation because of its high metabolic demand, which leads to this temporary vision loss.
Main Causes of Retinal Ischemia
The most common cause of transient retinal ischemia is thromboembolic events. Small fragments (cholesterol, fibrin-platelet, or calcium emboli) usually break off from atherosclerotic plaques in the ipsilateral carotid artery, the heart, or the aortic arch, and travel until they temporarily block the retinal arteries.
Other less common causes include:
- Retinal artery vasospasm
- Arterial dissection (such as carotid artery dissection)
- Vasculitis (especially giant cell arteritis)
- Hypercoagulable states
- In rare cases, transient increases in intraocular pressure or external ocular compression.
Characteristic Symptoms and How to Diagnose
The most distinctive symptom of AFx/rTIA is transient monocular vision loss (TMVL), often described as a "curtain" or "shadow" descending or rising across the visual field of the affected eye. The vision loss is sudden and lasts from seconds to several minutes, almost always resolving in less than an hour. If it lasts longer, it could indicate a retinal artery occlusion.
The diagnosis of AFx/rTIA is based on:
- A detailed medical history: It is crucial to ask about the nature of the visual loss, associated symptoms, and risk factors for vascular disease (such as hypertension, diabetes, or smoking).
- A complete physical examination: This includes a thorough neurological assessment to rule out persistent deficits. On fundus examination, the physician will look for Hollenhorst plaques, which are retinal emboli.
It is essential to differentiate rTIA from other causes of transient monocular vision loss, such as ocular migraine or visual obscurations associated with papilledema.
The Importance of a Rapid Assessment: Stroke Risk
rTIA is considered a medical emergency because of the significantly increased risk of a subsequent stroke. This risk can be 3% to 10% in the first two days and 9% to 17% in the first 90 days after the event, a risk similar to that of TIAs affecting the central nervous system (CNS).
Risk scores such as ABCD2 (and its modifications ABCD3 and ABCD-I) are used to assess stroke risk after a TIA.
Management and Treatment: Aggressive Stroke Prevention
Management of rTIA/AFx is similar to that of cerebral TIAs, focusing on stroke prevention.
An urgent diagnostic workup is recommended to identify underlying causes that can be addressed. This includes:
- Brain and vascular imaging: Such as carotid Doppler ultrasound and CT or MR angiography.
- Cardiac evaluation: Electrocardiogram (ECG) and echocardiogram.
- Laboratory tests.
Medical treatment commonly includes:
- Antiplatelet therapy: Aspirin or clopidogrel to reduce the risk of new ischemic events.
- Anticoagulation: Indicated in cases of cardioembolic sources, such as atrial fibrillation.
Risk factor modification is vital: controlling hypertension, diabetes, and hyperlipidemia, and quitting smoking. Lifestyle changes, such as a healthy diet and regular exercise, are also advised.
In patients with significant carotid stenosis, carotid endarterectomy or carotid stenting may be considered to reduce stroke risk. It is recommended that all patients with TIA/AFx receive antiplatelet therapy before a more complete evaluation. In high-risk patients, short-term dual antiplatelet therapy (aspirin and clopidogrel) may be considered.
The Critical Role of the Ophthalmologist in Diagnosis
Ophthalmologists are essential in the early recognition and appropriate management of rTIA. They should maintain a high index of suspicion in patients presenting with transient monocular vision loss, especially if they have known vascular risk factors.
It is essential to obtain a detailed history of the visual symptoms and perform a complete eye examination, looking for signs such as Hollenhorst plaques. Given the urgency of the stroke risk, immediate referral to a stroke center or a neurologist for a comprehensive systemic evaluation is imperative.
Amaurosis fugax and transient retinal ischemic attack are crucial manifestations of underlying vascular disease and significant predictors of future serious ischemic events. Their timely recognition and management are essential to reduce stroke risk and prevent permanent vision loss. Ophthalmologists play a vital role in the initial identification of these patients and facilitating rapid evaluation and treatment. Current guidelines emphasize the need to treat all TIAs, including AFx, as medical emergencies, with a focus on identifying the underlying etiology and implementing aggressive secondary prevention strategies.
Where can you find us?
- YouTube: Subscribe to our channel to watch full episodes and exclusive content: https://www.youtube.com/@SamurEyePodcast
- Instagram: Follow us on Instagram to hear about upcoming topics, guests and highlights: @samureyepodcast
- Spotify: Listen to our episodes wherever you go: https://open.spotify.com/show/2zMjQ14w1WdGDxBqrX4vEm?si=UIuMdz2YTueOnRqpiD6X6g
Join our community and let's delve into the fascinating world of ophthalmology together!
